Abstract:Alginate-poly-l-lysine-alginate (APA) microcapsules have proven effective in protecting enclosed live cells from immune rejection following transplantation into experimental animals, thereby eliminating the need for immunosuppressive therapy. However, in order for the capsules to remain intact for extended periods in vivo, the thickness of the membrane material must be optimized. In this study, the membrane thickness was examined as an indicator of membrane strength and measured under different reaction conditions. The thickness was found to increase 1) from 4.6 microns to 6.6 microns with an increase in the concentration of sodium alginate from 1.25 (w/v) to 2.0% (w.v); 2) from 4.2 microns to 6.2 microns with an increase in the concentration of the calcium solution from 20 mM to 100mM; 3) from 3.9 microns to 10.3 microns with an increase in the concentration of poly-l-lysine (PLL) from 0.02% (w/v) to 0.08% (w/v); and 4) from 2.3 microns to 7.4 microns with an increase in the reaction time with the PLL from two to seven minutes. On the other hand, membrane thickness decreased 1) from 9.8 microns to 8.6 microns with an increase of the pH in the PLL solution from 5.8 to 9.2; 2) from 13.2m to 5.8 microns with an increase in the molecular weight of PLL from 14,000 to 57,000; 3) from 8.4 microns to 6.0 microns with an increase in the treatment time with 0.9 (w/v) NaCl solution from zero to fifteen minutes and; 4) from 7.5 microns to 6.1 microns with an increase in the treatment time of the second sodium alginate coating from zero to ten minutes. Membrane thickness was inversely proportional to capsule volume expansion during membrane synthesis. By replacing calcium chloride by calcium lactate and eliminating the use of CHES in the construction of capsule membranes, we improved the strength and biocompatibility of our capsules, as evidenced by marked improvements in the survival rates of diabetic mice treated with islet transplants enclosed in the new capsules. These results indicate that it is possible to obtain optimal membrane thickness for a given purpose by creating specific reaction conditions under which membranes are synthesized.

Improving stability and biocompatibility of alginate/chitosan microcapsule by fabricating bi-functional membrane.

Improving Stability and Biocompatibility of Alginate/Chitosan Microcapsule by Fabricating Bi-Functional Membrane

Fabrication and formation studies on single-walled CA/NaCS-WSC microcapsules

Preparation and Characterization of NaCS–CMC/PDMDAAC Capsules

Enhanced Cellular Functions of Hepatocytes in the Hyaluronate-Alginate-chitosan Microcapsules

Improved membrane stability of alginate-chitosan microcapsules by crosslinking with tannic acid

Zwitterionically Modified Alginates Mitigate Cellular Overgrowth for Cell Encapsulation

Modification of chitosan membrane with poly(vinyl alcohol) and biocompatibility evaluation

Culture of yeast cells immobilized by alginate-chitosan microcapsules in aqueous-organic solvent biphasic system

Cytotoxicity study of novel water-soluble chitosan derivatives applied as membrane material of alginate microcapsules.

Effect of plasma components on the stability and permeability of microcapsule.

Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions

Biocompatibility of Phosphorylcholine Modified Alginate-Chitosan Microcapsules

Effect of Surface Wettability and Charge on Protein Adsorption Onto Implantable Alginate-Chitosan-Alginate Microcapsule Surfaces

Preliminary research on biocompatibility of alginate-chitosan-polyethyleneglycol microcapsules

The relationship between the inflammatory response and cell adhesion on alginate-chitosan-alginate microcapsules after transplantation.

Engineering superstable islets-laden chitosan microgels with carboxymethyl cellulose coating for long-term blood glucose regulation in vivo

Investigation of alginate-ε-poly-L-lysine microcapsules for cell microencapsulation.

Optimization and Characterization of Chitosan-Coated Alginate Microcapsules Containing Albumin.

Extending Viability of Bifidobacterium longum in Chitosan-Coated Alginate Microcapsules Using Emulsification and Internal Gelation Encapsulation Technology

Preparation and Characterization of Biocompatible Microcapsules of Sodium Cellulose Sulfate/Chitosan by Means of Layer-by-Layer Self-Assembly